false

m-content-container

/content/dam/corporate/images/stefs-test-images/_85a0229-copy.jpg

50%

A future without cervical cancer

m-hero--style-1

1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 800.533.2x.jpeg 1600w, 220.147.2x.jpeg 440w

false

Australia is set to be the first country to eliminate cervical cancer, with a national strategy to achieve the goal by 2035, aligned with a World Health Organization strategy to accelerate its global elimination. A team at the University of Sydney has led key research underpinning both strategies.

_self

Research for good

h2

Read about our 175-year history of research breakthroughs

A diagnosis no new mother expects

Just weeks after giving birth to her first child, Jenna received news that would change her life. 

"I was diagnosed with cervical cancer when my daughter was six weeks old," she says. 

Like many new parents, Jenna and her husband were adjusting to life with a newborn. 

“Those early days before diagnosis were as chaotic, love-filled and tiring as most first-time parents," she says. "I just didn't realise that love bubble was going to burst so quickly.” 

Jenna had always attended her regular cervical screenings and had never received an abnormal result. At her daughter's six-week check-up, her GP suggested she complete a routine screening test she had postponed during pregnancy. 

Then she got the call from her doctor, asking her to come in to discuss her results. 

“I remember thinking, ‘Am I going to see her grow up? Am I going to be there for her first day of school? Am I going to see the little girl and woman she'll become?’” 

Fortunately, the cancer was detected early, giving Jenna access to treatment options that preserved both her health and her future fertility. 

"If I hadn't received that screening, things could have been very different for me," she says. 

Jenna at home. Photo credit: Stefanie Zingsheim

50

automatic

Link

URL

embed-2b8b65ab94

Making public health history

Cervical cancer is one of the world's most preventable cancers, yet more than 600,000 women are diagnosed and around 280,000 die from it every year. 

It’s caused by a persistent infection with the human papillomavirus (HPV), making prevention possible through vaccination, screening and timely treatment. 

“Too often, women around the world are being diagnosed with or losing their lives to cervical cancer,” says Professor Karen Canfell AC, who leads the Cancer Elimination Collaboration (CEC) and the Elimination Partnership in Cervical Cancer (EPICC) at the University of Sydney’s School of Public Health.

“Many at a stage of life when they’re rearing children.”  

“Sadly, a woman dies of cervical cancer every two minutes,” she says. “But no woman should be dying of this disease, which is completely preventable and controllable.” 

For decades, Karen, her team and their collaborators, have conducted research informing advances in cervical cancer control policy, and making the case for elimination – a worldwide first for any cancer.

“Our team's work supported the renewal of the National Cervical Screening Program in Australia in 2017 – which moved from two-yearly Pap smears to five-yearly molecular HPV testing,” Karen says. 

Millions of Australians have now been screened using the HPV test, which identifies people at risk earlier and more accurately. 

Research by the now-CEC team and its collaborators also helped to pave the way for self-collection, allowing people to collect their own screening sample in private under the guidance of a healthcare professional. This has improved access for people who face barriers related to privacy, accessibility or past trauma. 

“Universal access to self-collection has been an absolute game changer for so many people,” Karen says. 

Professor Karen Canfell leads the Cancer Elimination Collaboration at the University of Sydney. Photo credit: Renee Nowytarger

35

manual

Link

Leading the world

Twenty years ago, the introduction of a vaccine for HPV, developed in Australia by Professor Ian Frazer and Dr Jian Zhou, with key contributions by Doug Lowy and John Schiller at the USA’s National Cancer Institute, was pivotal to the long-term potential to eliminate the disease.

Direct protection against cervical cancer through vaccination across the whole population will take several decades to achieve, as vaccination is mainly targeted to adolescents to protect them against a disease experienced later in life. Screening, with the new improved HPV test (replacing Pap tests) and optimal referral, is essential to reducing cervical cancer burden as the vaccine rollout runs its course.

Using advanced modelling, Karen and her collaborators showed that by meeting targets for coordinated vaccination, screening and treatment, cervical cancer could be eliminated worldwide within a century, saving 62 million lives over the long term. Their findings informed the World Health Organization’s global strategy for cervical cancer elimination, launched in 2020.  

“This is the first time the world has ever attempted to eliminate a major cancer,” Karen says. 

Australia’s well-established screening program, renewed and enhanced through policy changes informed by Karen and her team, along with a national vaccine rollout and universal health care, has set Australia on a path to be the first country to achieve elimination – by 2035. 

A federal government strategy for achieving this goal, also informed by the team and their collaborators, was launched in 2023.

However, the latest data shows that HPV vaccination coverage has fallen below 80 percent in both girls and boys for the first time since the program began in 2007, while cervical screening participation is lower than expected. 

Vaccine coverage below 80 percent is unlikely to be sufficient to cause widespread ‘herd protection’ against the targeted HPV types over the long term, prompting renewed calls to increase participation in both HPV vaccination and cervical screening programs.

Professor Karen Canfell and her team at the University of Sydney's Cancer Elimination Collaboration. Photo credit: Renee Nowytarger

50

automatic

Link

This is the first time the world has ever attempted to eliminate a major cancer.

Professor Karen Canfell

Lead, Cancer Elimination Collaboration

Leaving no one behind

The decline has been particularly pronounced among Aboriginal and Torres Strait Islander adolescents who experience higher rates of cervical cancer and mortality than other Australian women. This highlights the importance of culturally safe, community-led approaches and strong partnerships with Aboriginal Community Controlled Health Organisations and schools. 

"It's incredibly important to always keep an eye on who's being left behind and to have that absolute focus on equity," Karen says. 

“Australia's national elimination strategy is built on the principle that all women and people with a cervix should have access to prevention, screening and treatment, regardless of where they live, their cultural background, disability status or gender identity.” 

That challenge extends to Australia’s nearest neighbours where access to prevention, early detection and treatment remains limited. 

Addressing those inequities is key to the Elimination Partnership in Cervical Cancer (EPICC), led by Karen and the Cancer Elimination Collaboration alongside national and international partners, working with communities across the Indo-Pacific, including Indonesia, Malaysia, Timor-Leste, Papua New Guinea, Fiji, Tuvalu, Nauru, Vanuatu and the Solomon Islands.

A future without cervical cancer

Luckily for Jenna, lifesaving treatment at the Chris O'Brien Lifehouse was able to preserve her fertility, and she went on to have another child. She also started up a charity with her husband, called SurFebruary and helps raise funds for cancer research. 

As Australia works towards eliminating cervical cancer, Jenna hopes that future generations will never have to experience what she did. 

“I have so much hope for my daughter, her peers and the women coming through, that stories like mine will become less and less common,” she says. 

Karen shares that goal. 

“Ultimately, where a woman lives should no longer determine whether she develops and dies from cervical cancer.” 

 

Jenna overlooking Shelly Beach in Sydney. Photo credit: Stefanie Zingsheim

50

automatic

Link
The EPICC consortium is led by the CEC at the University of Sydney and includes the Australian Centre for the Prevention of Cervical Cancer, the Kirby Institute at UNSW Sydney, Family Planning Australia, the National Centre for Immunisation Research and Surveillance, Unitaid, the International Union for Cancer Control, the International Gynecological Cancer Society, the University of Texas MD Anderson Cancer Centre and Penn University Global Oncology.